Events Partner Content 9th Annual Biologics Formulation Development and Drug Delive... Formulation development for Safe Delivery to patient
Partner Content Partner Content Great time for pain research: exclusive interviews with indu... SMi Group reports: Ahead of 18th annual Pain Therapeutics Conference (London, 21 - 22 May) SMi Group have caught up with Neil S
Events Partner Content Fifth Annual Re-Entering Antibacterial Discovery and Develop... The Summit works to improve antimicrobial stewardship
Partner Content Partner Content 7th Annual HPAPI Summit - Boston 2018 Explore Unique Potent Compound Case Studies
Partner Content Partner Content Microbiome Drug Development Boston - Your Invite Pioneering The Microbiome Into Effective Medicines
Events Partner Content Microbiome Drug Development Boston 2018 Pioneering The Microbiome Into Effective Medicines
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.